Clinico-pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in India |
Malik, Prabhat Singh
(Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences)
Sharma, Mehar Chand (Department of Pathology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Mohanti, Bidhu Kalyan (Department of Radiation Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Shukla, N.K. (Department of Surgical Oncoloy, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Deo, S.V.S. (Department of Surgical Oncoloy, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Mohan, Anant (Department of Pulmonary Medicine, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Kumar, Guresh (Department of Biostatistics, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) Raina, Vinod (Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) |
1 | Field RW, Smith BJ, Platz CE, et al (2004). Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst, 96, 1105-7. DOI ScienceOn |
2 | Fry WA, Phillips JL, Menck HR.(1999). Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer, 86, 1867-76. DOI ScienceOn |
3 | Giovino GA (2002). Epidemiology of tobacco use in the United States. Oncogene, 21, 7326-40. DOI ScienceOn |
4 | Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44. DOI ScienceOn |
5 | Grivaux M, Zureik M, Marsal L, et al.(2011). Five-year survival for lung cancer patients managed in general hospitals. Rev Mal Respir, 28, 31-8. DOI ScienceOn |
6 | Janssen-Heijnen MLG, Coebergh J-WW (2003). The changing epidemiology of lung cancer in Europe. Lung Cancer, 41, 245-58. DOI ScienceOn |
7 | Khan NA, Afroz F, Lone MM, et al (2006). Profile of lung cancer in Kashmir, India: a five-year study. Indian J Chest Dis Allied Sci, 48, 187-90. |
8 | Mahmud SM, Reilly M, Comber H (2003). Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer, 41, 57-64. DOI ScienceOn |
9 | Mohan A, Goyal A, Singh P, et al (2006). Survival in small cell lung cancer in India: prognostic utility of clinical features, laboratory parameters and response to treatment. Indian J Cancer, 43, 67-74. DOI |
10 | Parkin DM FJ. GLOBOCAN 2008 V1.2, Cancer Incidence and Mortality Worldwide [Internet]. IARC Cancer Base No.10; Available from: http://globocan.iarc.fr |
11 | Prasad R, James P, Kesarwani V, et al (20004). Clinicopathological study of bronchogenic carcinoma. Respirology, 9, 557-60. DOI ScienceOn |
12 | Scagliotti G, Brodowicz T, Shepherd FA, et al (2011). Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J Thorac Oncol, 6, 64-70 |
13 | Singh N, Aggarwal AN, Gupta D, et al (2010). Unchanging clinico-epidemiological profile of lung cancer in north India over three decades. Cancer Epidemiol, 34, 101-4. DOI ScienceOn |
14 | Standfield L, Weston AR, Barraclough H, et al (2011). Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. Respirology, 16, 1210-20. DOI ScienceOn |
15 | Stevens W, Stevens G, Kolbe J, et al (2007). Lung cancer in New Zealand: patterns of secondary care and implications for survival. J Thorac Oncol, 2, 481-93. DOI |
16 | Thun MJ, Henley SJ, Burns D, et al. (2006). Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst, 98, 691-9. DOI ScienceOn |
17 | Valaitis J, Warren S, Gamble D (1981). Increasing incidence of adenocarcinoma of the lung. Cancer, 47, 1042-6. DOI ScienceOn |
18 | Albain KS, Crowley JJ, LeBlanc M, et al (1990). Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient southwest oncology group data base. J Clin Oncol, 8, 1563-74. |
19 | Albain KS, Crowley JJ, LeBlanc M, et al (1991). Survival determinants in extensive-stage non-small-cell lung cancer: the southwest oncology group experience. J Clin Oncol, 9, 1618-26. |
20 | Behera D, Balamugesh T (2004). Lung cancer in India. Indian J Chest Dis Allied Sci, 46, 269-81. |
21 | Blanchon F, Grivaux M, Asselain B, et al (2006). 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol, 7, 829-36. DOI ScienceOn |
22 | Cetin K, Ettinger DS, Hei Y-J, et al (2011). Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program. Clin Epidemiol, 3, 139-48. |
23 | Cooper WA, O'toole S, Boyer M, et al (2011). What' new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Pathology, 43, 103-15. DOI ScienceOn |
24 | Cykert S, Dilworth-Anderson P, Monroe MH, et al (2010). Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA, 303, 2368-76. DOI ScienceOn |
25 | Delaney G, Jacob S, Featherstone C, et al (2005). The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer, 104, 1129-37. DOI ScienceOn |
26 | Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. DOI ScienceOn |
27 | Erridge SC, Murray B, Price A, et al (2008). Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol, 3, 491-8. DOI ScienceOn |
28 | Esnaola NF, Gebregziabher M, Knott K, et al (2008). Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg, 86, 220-6. DOI ScienceOn |
29 | Ettinger DS. NCCN Clinical Practice Guidelines in Oncology for Non Small Cell Lung Cancer, Ver 2.2012 [Internet]. Natinal Comprehensive Cancer Network; 2012. Available from: www.nccn.com |
30 | Vineis P, Alavanja M, Buffler P, et al (2004). Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst, 96, 99-106. DOI ScienceOn |
31 | Vinod SK, O’Connell DL, Simonella L, et al (2008). Gaps in optimal care for lung cancer. J Thorac Oncol, 3, 871-9. DOI ScienceOn |
32 | Vinod SK, Sidhom MA, Gabriel GS, et al (2010). Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol, 5, 1025-32. |
33 | Wakelee HA, Chang ET, Gomez SL, et al (2007). Lung cancer incidence in never smokers. J Clin Oncol, 25, 472-8. DOI ScienceOn |